These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24899636)

  • 1. Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus.
    López-López L; Nieves-Plaza M; Castro Mdel R; Font YM; Torres-Ramos CA; Vilá LM; Ayala-Peña S
    Lupus; 2014 Oct; 23(11):1133-41. PubMed ID: 24899636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Cruz JJ; Ríos-Olivares E; Ríos Z
    Clin Rheumatol; 2007 May; 26(5):718-22. PubMed ID: 16924394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus.
    Lee HT; Lin CS; Lee CS; Tsai CY; Wei YH
    Clin Exp Immunol; 2014 Apr; 176(1):66-77. PubMed ID: 24345202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus.
    Al-Shobaili HA; Rasheed Z
    Lupus; 2013 Sep; 22(10):1024-37. PubMed ID: 23884988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Damage accrual in systemic lupus erythematosus in Dominicans in New York City and the Dominican Republic.
    Geraldino-Pardilla L; Kapoor T; Canto I; Perez-Recio T; Then J; Tineo C; Loyo E; Askanase A
    Lupus; 2018 Oct; 27(12):1989-1995. PubMed ID: 30092732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.
    Montes RA; Mocarzel LO; Lanzieri PG; Lopes LM; Carvalho A; Almeida JR
    Arthritis Rheumatol; 2016 Feb; 68(2):441-8. PubMed ID: 26359794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of reversion-inducing cysteine-rich protein with Kazal motifs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus: links to disease activity, damage accrual and matrix metalloproteinase 9 secretion.
    Hou C; Zhang Y
    J Int Med Res; 2008; 36(4):704-13. PubMed ID: 18652766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
    Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
    Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry.
    Morishita M; Sada KE; Ohashi K; Miyawaki Y; Asano Y; Hayashi K; Asano SH; Yamamura Y; Watanabe H; Narazaki M; Matsumoto Y; Kawabata T; Yajima N; Wada J
    Lupus; 2020 Feb; 29(2):176-181. PubMed ID: 31924143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of T cell recombination excision circles levels in peripheral blood mononuclear cells of systemic lupus erythematosus patients].
    Du ZY; Leng XM; Tang FL
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):500-3. PubMed ID: 20979738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus.
    Giaglis S; Daoudlarian D; Voll RE; Kyburz D; Venhoff N; Walker UA
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34916301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New classification criteria for systemic lupus erythematosus correlate with disease activity.
    Anić F; Zuvić-Butorac M; Stimac D; Novak S
    Croat Med J; 2014 Oct; 55(5):514-9. PubMed ID: 25358884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
    Quintana R; Pons-Estel GJ; Roberts K; Sacnún M; Serrano R; Nieto R; Conti S; Gervasoni V; Catoggio LJ; Soriano ER; Scolnik M; García MA; Alvarellos A; Saurit V; Berbotto GA; Sato EI; Costallat LTL; Neto EFB; Bonfa E; Xavier RM; de Oliveira E Silva Montandon AC; Molina-Restrepo JF; Iglesias-Gamarra A; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Torre IG; Acevedo-Vásquez EM; Ugarte-Gil MF; Alfaro-Lozano JL; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Gomez-Puerta JA; Alarcón GS; Pons-Estel BA
    Lupus; 2020 Aug; 29(9):1140-1145. PubMed ID: 32605527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
    Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
    Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
    Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
    Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.